Form 4 for RNXT RenovoRx, Inc.
Accepted 2026-05-21 07:00:14 ET · period of report 2026-05-19 · accession 0001493152-26-024726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 07:00 | 2026-05-19 | RNXT | VOLL MARK | CFO | P - Purchase | $0.7876 | +25.0K | 142.4K | +21% | +$19.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | P | A | 25,000 | $0.7876 | 142,380 | D | — | — | (F1) Reflects open market purchases of the Issuer's securities. (F2) A grant of 58,953 restricted stock units ("RSUs") was previously reported for the Reporting Person's future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed. As of April 30, 2026, 8,823 of such RSUs had vested, leaving a remaining balance of 50,130 unvested RSUs. |